On June 2, 2022, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) hosted a Roundtable on Access to Multi-disease Molecular Diagnostics, which brought together country program representatives, donors, members of civil society, and other global health actors to:
- Identify ways to leverage the availability of new multi-disease molecular diagnostic platforms to create a more competitive market for COVID-19, HIV, TB, HBV, HCV, HPV, and STI testing;
- Identify points of consensus on evidence-based pricing and innovative models for procurement, service, and maintenance; and
- Develop a set of shared principles that can be applied across actors and diseases in future negotiations with diagnostics suppliers.
The meeting report and presentations are available for download in the right sidebar.
The Shared Principles for Access to Multi-disease Molecular Diagnostics, developed based on areas of consensus that emerged during the Roundtable, will also be made available for download here soon.